Global Radiopharmaceuticals Market – Products and Applications

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Radiopharmaceuticals Introduction
1.1.2 What are Radiopharmaceuticals?
1.1.2.1 Historical Timeline – Radiopharmaceuticals
1.1.2.2 Radiopharmaceutical Nomenclature
1.1.2.3 Radiation Measurement Units
1.1.2.4 Route of Administration
1.1.2.5 Prerequisites for Nuclear Imaging
1.1.2.6 Possible Complications of Radioisotopes
1.1.2.7 Misadministration of Radiopharmaceuticals
1.1.3 Radiopharmaceuticals Production
1.1.3.1 Cyclotron
1.1.3.2 Nuclear Reactor
1.1.3.3 Radionuclide Generator
1.1.4 Benefits and risks of Nuclear Imaging
1.1.4.1 Benefits
1.1.4.2 Risks
1.1.5 Radiopharmaceuticals Segmentation Based on Usage
1.1.5.1 Diagnostic Radiopharmaceuticals
1.1.5.2 Therapeutic Radiopharmaceuticals
1.1.6 Some Important Radiotracers
1.1.6.1 Technetium-99m
1.1.6.2 TL-201
1.1.6.3 Ga-67
1.1.6.4 I-123
1.1.6.5 F-18
1.1.6.6 Ra-223
1.1.6.7 I-131
1.1.6.8 I-125
1.1.6.9 Ir-192
1.1.7 Types of Radiopharmaceuticals
1.1.7.1 SPECT Radioisotopes
1.1.7.2 PET Radioisotopes
1.1.7.3 Beta Emitters
1.1.7.4 Alpha Emitters
1.1.7.5 Brachytherapy
1.1.7.5.1 Temporary Brachytherapy
1.1.7.5.2 Permanent Brachytherapy
1.1.7.6 Auger Electron
1.1.7.7 Coster-Kronig Electron
1.1.8 Applications of Radiopharmaceuticals
1.1.8.1 Oncology
1.1.8.2 Cardiology
1.1.8.3 Neurology
1.1.8.4 Endocrinology
1.1.8.5 Other Applications
1.1.9 Radiopharmaceuticals Approval Procedure
1.1.9.1 The United States
1.1.9.2 Europe

2. KEY MARKET TRENDS
2.1 Recurrent Prostate Cancer Detection by a New PET Radiopharmaceutical
2.2 Radiopharmaceuticals Enable Easy Monitorization of Rheumatoid Arthritis
2.3 68Ga-FAPI Radiotracer – A Novel Tracer Capable of Detecting Approximately Thirty Cancer Types
2.4 Novel SV2A PET Tracer for Neurodegenerative Disorder
2.5 New Therapeutic Radiotracers for Malignant Neuroendocrine Tumors
2.6 Copper – A Promising Novel Theranostic Radiopharmaceutical
2.7 A Novel PET Radioisotope Tool to Diagnose Brain Disorders
2.8 [18F]RO-948 - Tau PET Radiopharmaceuticals for Alzheimer’s Disease
2.9 Particle Accelerator Capable of Producing Technetium-99m Radioisotope
2.10 Treatment Response Prediction of Bone-Dominant Metastatic Breast Cancer by PET Radiotracer

3. KEY GLOBAL PLAYERS

• Advanced Accelerator Applications SA (France)
• Alpha Tau Medical Ltd. (Israel)
• Bayer AG (Germany)
• Blue Earth Diagnostics Limited (United Kingdom)
• Bracco Diagnostics, Inc. (United States)
• Cardinal Health, Inc. (United States)
• Clarity Pharmaceuticals (Australia)
• Curium Pharma (France)
• Eckert & Ziegler Group (Germany)
• Eczacibasi-Monrol (Turkey)
• GE Healthcare (United States)
• Ion Beam Applications SA (IBA) (Belgium)
• Jubilant DraxImage, Inc. dba Jubilant Radiopharma (Canada)
• Lantheus Medical Imaging, Inc. (United States)
• Life Molecular Imaging GmbH (Germany)
• NTP Radioisotopes SOC Ltd. (South Africa)
• Orano Med (France)
• Siemens Healthineers (Germany)
• Telix Pharmaceuticals Limited (Australia)

4. KEY BUSINESS AND PRODUCT TRENDS

• Clarity Pharmaceuticals Files ODD Request for 64Cu-SARTATE™
• Theranostic IND Application for 64Cu-SARTATE™ and 67Cu-SARTATE™ Filed by Clarity Pharmaceuticals
• IBA Installs Cyclone® 70 Cyclotron System in Cape Town, South Africa
• Eckert & Ziegler and Alpha Tau Form Thorium-228 Supply Pact
• Varian Installs Cyclotron for ProBeam® Proton Therapy System at Sylvester Comprehensive Cancer Center
• Blue Earth Diagnostics Acquired by Bracco Imaging
• TCL Eckert & Ziegler BEBIG Healthcare to Produce and Market Tumor Irritation Devices in China
• IBA Installs Cyclone® 70 System in Daejeon, South Korea
• New Radiopharmaceutical Production Unit Established by EZAG in China
• NorthStar Enhances the Production Capacity of Non-Uranium Based Radioisotopes
• Swedish Karolinska University Hospital Employs Varian's Bravos™ Afterloader System for HDR Brachytherapy Treatment
• New Molybdenum-99 Processing Facility Established by NorthStar in Beloit, Wisconsin
• Varian Installs Cyclotron for ProBeam® Proton Therapy System at King Chulalongkorn Memorial Hospital in Bangkok
• Doctors Hospital in Mexico Installed with New Synthera® Platform
• Progenics' AI Research Program to Explore Novel Machine Learning Algorithms in Medical Imaging
• DuChemBio to Produce and Market Life Molecular Imaging's NeuraCeq™ in Philippines
• ANSTO's National Research Cyclotron Facility to Manufacture F-18 Radiotracers
• US FDA Issues 510(k) Clearance for DOSIsoft's Planet Onco Dose Software
• First Clinical Installation of United Imaging's uMI 550 Digital PET/CT System in the United States
• Vivos Receives License for Administering IsoPet® for Animal Therapy
• Launch of IMWG's First Set of New Recommendations for Multiple Myeloma Imaging Techniques
• Cancer Treatment Services International Acquired by Varian
• Launch of Jubilant Radiopharma
• CE Marking for Jubilant DraxImage's RUBY Rubidium Elution System and Proprietary RUBY Consumable Accessories
• New Production Method for Medical Imaging Radioisotopes Unveiled by BGN Technologies
• Integrated Use of NeuraCeq™ and PI-2620 Radiotracers for Brain PET Imaging in Thailand
• Fujifilm Toyama Chemical Takeover Progenics' Automated Bone Scan Index Product in Japan
• Varian Installs Cyclotron for ProBeam® Proton Therapy System at Biopolis
• New Multi-Room Proton Clinical Research Center of Shandong Cancer Hospital Equipped with Varian ProBeam® Proton Therapy System
• CyberHeart Acquired by Varian
• Cyclone® KIUBE Installation Increases ICNAS' Radiopharmaceutical Production
• ROTOP to Develop and Commercialize Progenics' 1404 Prostate Cancer Imaging Agent in Europe
• Cyclotron for Varian ProBeam® Compact Proton Therapy System Installed at Hefei Ion Medical Center
• IRAB to Produce Life Molecular Imaging's NeuraCeq™ and Pl-2620 in Barcelona
• Orano Med Invests 15 Million Euros to Enhance the Production of Cancer Therapeutic Solutions
• Cyclone® KIUBE Cycalotron Equipped at Costa Rice University
• Coquí's Medical Isotope Production Facility Built in Oak Ridge, Tennessee
• NorthStar Acquires IBA's Eight Rhodotron® TT300 HE Electron Beam Accelerators
• INCART to Produce FDG
• RadioMedix to Develop Vect-Horus Theranostic Agent for Glioblastoma Multiforme
• EZAG Completes Merger of EZB
• First Commercial Production of Blue Earth Diagnostics' Axumin® in Italy
• Health Canada Approves AAA's Lutathera™ for GEP-NETs Treatment
• GE Healthcare Installs PETtrace 880 Cyclotron at KIRAMS
• AZEDRA® Production Facility in Somerset, New Jersey Acquired by Progenics
• Bacon Lab in Argentina Starts Clinical Trials with 18F-PSMA-1007
• HUS Imaging to Kick-off FDG Production
• Curium to Develop and Commercialize Progenics' PyL™ Prostate Cancer Imaging Agent in Europe
• RadioMedix' 64Cu-Dotatate Receives Fast Track Designation from US FDA
• Endocyte Acquired by Novartis
• First Commercial Production of Blue Earth Diagnostics' Axumin® in France
• US FDA Accepted for sNDA Review to Employ Axumin® for Glioma Assessment
• USPTO Extends Patent Term for Lymphoseek®
• AAA to Develop and Commercialize Fujifilm Toyama Chemical's FF-10158 for Oncology Indications
• CIMEQ to Produce FDG in Cuba
• Advanced Nuclear Medicine Ingredients SA Acquired by Telix Pharmaceuticals
• US FDA Grants ODD to Employ AlphaMedix™ for Neuroendocrine Tumor Treatment
• Novartis to Broaden RLT platform by Acquiring Endocyte
• GMP Production Deal Signed by Telix and RTM for Kidney Imaging
• Seibersdorf Laboratories to Produce Telix' Glioblastoma Therapeutics
• Telix Pharmaceuticals Joined Forces with Cardinal Health for the Supply of 68Ga-PSMA Kit in US
• Fujifilm Toyama Chemical to Develop Novel Diagnostic and Therapeutic Drugs
• NorthStar Awarded as the First Molybdenum-99 Producer in US
• Ruffani Quality Solutions is the New Local Partner of Trasis in Germany and Austria
• Trasis Produces PSMA Based Radiotracers on AllinOne Family Synthesizer
• Trasis' FDG Dual Method Receives Market Authorization for Belgium and the Netherlands
• XingImaging Sites in China to Produce Life Molecular Imaging's PI2620
• Atlab Pharma Purchased by Telix Pharmaceuticals
• Life Molecular Imaging is the New Name of Piramal Imaging
• Novel Phospholipid Drug Conjugate Co-developed by Cellectar and Orano Med
• Curium to Develop and Commercialize RadioMedix' 64Cu-Dotatate
• US FDA Approves NorthStar's Beloit Manufacturing Facility for RadioGenix™ System Production
• US FDA Issues 510(k) Regulatory Clearance for IsoRay's GammaTile™ Therapy
• US FDA Approves NDA for Progenics' AZEDRA® (iobenguane I 131) 555 MBq/mL Injection
• RadioMedix to Produce and Supply Next Generation ITG Ge-68 / Ga-68 Generators
• Installation of the First New Generation IBA Cyclone® KIUBE Cyclotron in Russia
• Piramal Imaging Acquired by Alliance Medical
• IASON to Produce and Distribute Blue Earth Diagnostics' Axumin® in Poland
• IBA Cyclone® KIUBE 300 has the Highest Production Capacity Ever Reached by a PET Cyclotron
• IBA Cyclone® 18 Placed in Vault at Muni Seva Ashram in India
• Installation of IBA Cyclone® 70 System at AZI in United States
• AtomExpo Award Received by NTP Radioisotopes
• Blue Earth Diagnostics Acquires Selective Global Licensing Rights of Scintomics' rhPSMA-targeted Agents for Cancer Imaging
• SWAN Isotopen AG to Produce and Distribute Piramal Imaging's Neuraceq™ in Switzerland
• Curium Re-Introduces Xenon Xe 133 Gas
• Cyclopharma's Production and Commercial Operations in France Acquired by Curium
• Meilleur to Develop and Commercialize Navidea's NAV4694 Imaging Agent
• Permanent Shut Down of Canada's National Research Universal
• Cyclone® 18 at JFE Site Set for Radioisotope Production
• Cyclone® KIUBE to be Installed at GMS Taichung Production Facility in Taiwan
• Positron Pharma to Produce and Distribute Piramal Imaging's Neuraceq™ Imaging Agent
• NorthStar's RadioGenix™ System Receives US FDA Approval
• Advanced Accelerator Applications to Develop and Market F-18-labeled CTT1057
• Successful Rigging of Cyclone® 18/9 at CNUH in South Korea
• Isologic to Distribute IRE-ELiT's Galli Eo® 68Ge / 68Ga Generator in Canada
• World's First Prostate Cancer Surgery Using Blu Build Cesium-131 Brachytherapy System by MUSC's Hollings Cancer Center
• DaTscan™, the First Imaging Agent for Parkinsonian Syndrome Diagnosis Approved by Health Canada
• Advanced Medical Isotope Corporation Renamed as Vivos Inc.
• US FDA Approves AAA's LUTATHERA® to Treat Somatostatin Receptor Positive GEP-NETs
• Curium, the First and Only Producer in North America Offering 100% LEU TC 99m Generators
• Successful Rigging of Cyclone® Cyclotrons on Different Continents
• US FDA Approves New Pulmonary Indications for Jubilant DraxImage's DRAXIMAGE® DTPA Kit
• Memorial Sloan Kettering Cancer Center Employs Telix' 89Zr-girentuximab
• Patent Application on University of Melbourne's PSMA Prostate Cancer Targeting Agent In-Licensed by Clarity
• Cyclone® 18 Rigged at CIMEQ in Cuba
• US FDA Approves for the Extension of the In-Use Shelf Life of Jubilant DraxImage's DRAXIMAGE® MAA
• Telix to Develop and Commercialize ANMI's 68Ga-PSMA-11 Kit in US
• RadioMedix to Distribute ITG's n.c.a. Lutetium-177 in North America
• Triad's US Radiopharmacy Business Acquired by Jubilant Pharma
• NNSA and NTP Completes Molybdenum-99 Conversion Project
• Cardinal Health to Distribute IRE-ELiT's Galli Eo® 68Ge/68Ga Generator in North America
• Varian to Distribute Bionix® Brachytherapy Applicators in North America
• Telix Pharmaceuticals Completed Master Services Agreement with Cyclotek
• Sayre Therapeutics to Develop and Commercialize Navidea's Tc 99m Tilmanocept in India
• SpePharm AG Launches Navidea's LYMPHOSEEK® Tc 99m Tilmanocept
• EC Grants Marketing Authorisation for Blue Earth Diagnostics' Axumin™
• ARTMS Products and Alliance Medical Join Forces to Demonstrate a Viable Alternative
• Alliance Medical to Takeover Eckert & Ziegler's Cyclotron Division
• Cyclone® 18 Placed into Vault at INCART
• Implementation of 18F-PSMA-1007 on IBA Synthera® Platform
• Unveiling of IBA's Novel Fixed IFP™ Cassette at an Expo in Germany
• Trasis Joined Forces with Herlev Hospital to Produce 18F NaF and 18F FDOPA on Daily Basis
• ANSTO Researchers Developed Novel PET Radiotracer Production Process
• Curium, Merger of IBA Molecular and Mallinckrodt Nuclear Medicine LLC
• Cardinal Health Purchased Licensing Rights of Navidea's Lymphoseek® in North America
• University of Missouri Research Reactor to Supply Lutetium 177 to Advanced Accelerator Applications
• Health Canada Issues Notice of Compliance to ISOLOGIC Innovative Radiopharmaceuticals for NeuraCeq™
• All Medrad Intego PET Infusion System Source Administration Sets Recalled by Bayer

5. GLOBAL MARKET OVERVIEW
5.1 Global Radiopharmaceuticals Market Overview by Product Type
5.1.1 Radiopharmaceuticals Product Type Market Overview by Global Region
5.1.1.1 SPECT Radioisotopes
5.1.1.2 PET Radioisotopes
5.1.1.3 Beta Emitters
5.1.1.4 Alpha Emitters
5.1.1.5 Other Radiopharmaceuticals
5.2 Global Radiopharmaceuticals Market Overview by Application
5.2.1 Radiopharmaceuticals Application Market Overview by Global Region
5.2.1.1 Oncology
5.2.1.2 Cardiology
5.2.1.3 Neurology
5.2.1.4 Endocrinology
5.2.1.5 Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA
6.1 North American Radiopharmaceuticals Market Overview by Geographic Region
6.2 North American Radiopharmaceuticals Market Overview by Product Type
6.2.1 Radiopharmaceuticals Product Type Market Overview by NA Region
6.2.1.1 SPECT Radioisotopes
6.2.1.2 PET Radioisotopes
6.2.1.3 Beta Emitters
6.2.1.4 Alpha Emitters
6.2.1.5 Other Radiopharmaceuticals
6.3 North American Radiopharmaceuticals Market Overview by Application
6.3.1 Radiopharmaceuticals Application Market Overview by NA Region
6.3.1.1 Oncology
6.3.1.2 Cardiology
6.3.1.3 Neurology
6.3.1.4 Endocrinology
6.3.1.5 Other Applications
6.4 Major Market Players

• Actinium Pharmaceuticals, Inc. (United States)
• Bracco Diagnostics, Inc. (United States)
• Cardinal Health, Inc. (United States)
• Coquí Pharma (United States)
• Fusion Pharmaceuticals, Inc. (Canada)
• GE Healthcare (United States)
• Isologic Innovative Radiopharmaceuticals Ltd. (Canada)
• Isoray Medical, Inc. (United States)
• Jubilant DraxImage, Inc. dba Jubilant Radiopharma (Canada)
• Lantheus Medical Imaging, Inc. (United States)
• Navidea Biopharmaceuticals, Inc. (United States)
• NorthStar® Medical Radioisotopes LLC (United States)
• Pharmalucence, Inc. (United States)
• Progenics Pharmaceuticals, Inc. (United States)
• Radiomedix, Inc. (United States)
• Vivos, Inc. (United States)
• Zevacor Molecular (Unite States)

6.5 Country-wise Analysis of North American Radiopharmaceuticals Market
6.5.1 The United States
6.5.1.1 United States Radiopharmaceuticals Market Overview by Product Type
6.5.1.2 United States Radiopharmaceuticals Market Overview by Application

6.5.2 Canada
6.5.2.1 Canadian Radiopharmaceuticals Market Overview by Product Type
6.5.2.2 Canadian Radiopharmaceuticals Market Overview by Application

7. EUROPE
7.1 European Radiopharmaceuticals Market Overview by Geographic Region
7.2 European Radiopharmaceuticals Market Overview by Product Type
7.2.1 Radiopharmaceuticals Product Type Market Overview by European Region
7.2.1.1 SPECT Radioisotopes
7.2.1.2 PET Radioisotopes
7.2.1.3 Beta Emitters
7.2.1.4 Alpha Emitters
7.2.1.5 Other Radiopharmaceuticals
7.3 European Radiopharmaceuticals Market Overview by Application
7.3.1 Radiopharmaceuticals Application Market Overview by European Region
7.3.1.1 Oncology
7.3.1.2 Cardiology
7.3.1.3 Neurology
7.3.1.4 Endocrinology
7.3.1.5 Other Applications
7.4 Major Market Players

• Advanced Accelerator Applications SA (France)
• Alliance Medical Limited (The United Kingdom)
• Bayer AG (Germany)
• Blue Earth Diagnostics Limited (The United Kingdom)
• Curium Pharma (France)
• Eckert & Ziegler Group (Germany)
• Ion Beam Applications SA (IBA) (Belgium)
• IRE - IRE ELiT (Belgium)
• Life Molecular Imaging GmbH (Germany)
• Medi-Radiopharma Co., Ltd. (Hungary)
• National Centre for Nuclear Research Radioisotope Centre POLATOM (Poland)
• Orano Med (France)
• Siemens Healthineers (Germany)
• TRASIS (Belgium)

7.5 Country-wise Analysis of European Radiopharmaceuticals Market
7.5.1 Germany
7.5.1.1 German Radiopharmaceuticals Market Overview by Product Type
7.5.1.2 German Radiopharmaceuticals Market Overview by Application

7.5.2 The United Kingdom
7.5.2.1 United Kingdom Radiopharmaceuticals Market Overview by Product Type
7.5.2.2 United Kingdom Radiopharmaceuticals Market Overview by Application

7.5.3 France
7.5.3.1 French Radiopharmaceuticals Market Overview by Product Type
7.5.3.2 French Radiopharmaceuticals Market Overview by Application

7.5.4 Italy
7.5.4.1 Italian Radiopharmaceuticals Market Overview by Product Type
7.5.4.2 Italian Radiopharmaceuticals Market Overview by Application

7.5.5 Sweden
7.5.5.1 Swedish Radiopharmaceuticals Market Overview by Product Type
7.5.5.2 Swedish Radiopharmaceuticals Market Overview by Application

7.5.6 Rest of Europe
7.5.6.1 Rest of Europe Radiopharmaceuticals Market Overview by Product Type
7.5.6.2 Rest of Europe Radiopharmaceuticals Market Overview by Application

8. ASIA-PACIFIC
8.1 Asia-Pacific Radiopharmaceuticals Market Overview by Geographic Region
8.2 Asia-Pacific Radiopharmaceuticals Market Overview by Product Type
8.2.1 Radiopharmaceuticals Product Type Market Overview by Asia-Pacific Region
8.2.1.1 SPECT Radioisotopes
8.2.1.2 PET Radioisotopes
8.2.1.3 Beta Emitters
8.2.1.4 Alpha Emitters
8.2.1.5 Other Radiopharmaceuticals
8.3 Asia-Pacific Radiopharmaceuticals Market Overview by Application
8.3.1 Radiopharmaceuticals Application Market Overview by Asia-Pacific Region
8.3.1.1 Oncology
8.3.1.2 Cardiology
8.3.1.3 Neurology
8.3.1.4 Endocrinology
8.3.1.5 Other Applications
8.4 Major Market Players

• Australian Nuclear Association and Technology Organization (Australia)
• Board of Radiation & Isotope Technology (BRIT) (India)
• China Isotope & Radiation Corporation (CIRC) (China)
• Clarity Pharmaceuticals (Australia)
• FUJIFILM Toyama Chemical Co., Ltd. (Japan)
• Nihon Medi-Physics Co., Ltd. (Japan)
• Telix Pharmaceuticals Limited (Australia)

8.5 Country-wise Analysis of Asia-Pacific Radiopharmaceuticals Market
8.5.1 Japan
8.5.1.1 Japanese Radiopharmaceuticals Market Overview by Product Type
8.5.1.2 Japanese Radiopharmaceuticals Market Overview by Application

8.5.2 China
8.5.2.1 Chinese Radiopharmaceuticals Market Overview by Product Type
8.5.2.2 Chinese Radiopharmaceuticals Market Overview by Application

8.5.3 India
8.5.3.1 Indian Radiopharmaceuticals Market Overview by Product Type
8.5.3.2 Indian Radiopharmaceuticals Market Overview by Application

8.5.4 Australia
8.5.4.1 Australian Radiopharmaceuticals Market Overview by Product Type
8.5.4.2 Australian Radiopharmaceuticals Market Overview by Application

8.5.5 South Korea
8.5.5.1 South Korean Radiopharmaceuticals Market Overview by Product Type
8.5.5.2 South Korean Radiopharmaceuticals Market Overview by Application

8.5.6 Rest of Asia-Pacific
8.5.6.1 Rest of Asia-Pacific Radiopharmaceuticals Market Overview by Product Type
8.5.6.2 Rest of Asia-Pacific Radiopharmaceuticals Market Overview by Application

9. REST OF WORLD
9.1 Rest of World Radiopharmaceuticals Market Overview by Geographic Region
9.2 Rest of World Radiopharmaceuticals Market Overview by Product Type
9.2.1 Radiopharmaceuticals Product Type Market Overview by Rest of World Region
9.2.1.1 SPECT Radioisotopes
9.2.1.2 PET Radioisotopes
9.2.1.3 Beta Emitters
9.2.1.4 Alpha Emitters
9.2.1.5 Other Radiopharmaceuticals
9.3 Rest of World Radiopharmaceuticals Market Overview by Application
9.3.1 Radiopharmaceuticals Application Market Overview by Rest of World Region
9.3.1.1 Oncology
9.3.1.2 Cardiology
9.3.1.3 Neurology
9.3.1.4 Endocrinology
9.3.1.5 Other Applications
9.4 Major Market Players

• Alpha Tau Medical Ltd. (Israel)
• Eczacibasi-Monrol (Turkey)
• NTP Radioisotopes SOC Ltd. (South Africa)

9.5 Country-wise Analysis of Rest of World Radiopharmaceuticals Market
9.5.1 Mexico
9.5.1.1 Mexican Radiopharmaceuticals Market Overview by Product Type
9.5.1.2 Mexican Radiopharmaceuticals Market Overview by Application

9.5.2 Brazil
9.5.2.1 Brazilian Radiopharmaceuticals Market Overview by Product Type
9.5.2.2 Brazilian Radiopharmaceuticals Market Overview by Application

9.5.3 Other Rest of World
9.5.3.1 Other ROW Countries Radiopharmaceuticals Market Overview by Product Type
9.5.3.2 Other ROW Countries Radiopharmaceuticals Market Overview by Application

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Radiopharmaceuticals Market (2018 & 2025) by Geographic Region
Chart 2: Global Radiopharmaceuticals Market (2018 & 2025) by Product Type
Chart 3: Global Radiopharmaceuticals Market (2018 & 2025) by Application
Chart 4: Global Radiopharmaceuticals Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 5: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 6: Global Radiopharmaceuticals in Oncology Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 7: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals in Oncology Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 8: Global Radiopharmaceuticals in Cardiology Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 9: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals in Cardiology Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 10: Global Radiopharmaceuticals in Neurology Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 11: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals in Neurology Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 12: Global Radiopharmaceuticals in Endocrinology Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 13: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals in Endocrinology Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 14: Global Radiopharmaceuticals in Other Applications Market Analysis (2016-2025) by Product Segment – Diagnostic and Therapeutic in USD Million
Chart 15: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals in Other Applications Market Share (%) by Product Segment – Diagnostic and Therapeutic
Chart 16: Global Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 17: Global Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 18: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 19: Global SPECT Radioisotopes Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2016, 2019 and 2025 Global SPECT Radioisotopes Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 21: Global PET Radioisotopes Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2016, 2019 and 2025 Global PET Radioisotopes Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 23: Global Beta Emitters Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2016, 2019 and 2025 Global Beta Emitters Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 25: Global Alpha Emitters Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 26: Glance at 2016, 2019 and 2025 Global Alpha Emitters Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 27: Global Other Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2016, 2019 and 2025 Global Other Radiopharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 29: Global Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 30: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other
Chart 31: Global Radiopharmaceuticals Market Analysis (2016-2025) in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 33: Global Radiopharmaceuticals Market Analysis (2016-2025) in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 34: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 35: Global Radiopharmaceuticals Market Analysis (2016-2025) in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 36: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 37: Global Radiopharmaceuticals Market Analysis (2016-2025) in Endocrinology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 38: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) in Endocrinology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 39: Global Radiopharmaceuticals Market Analysis (2016-2025) in Other Applications by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 40: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) in Other Applications by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE
Chart 41: Global Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 42: Glance at 2016, 2019 and 2025 Global Radiopharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 43: North American Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 44: North American Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 45: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) by Geographic Region – United States and Canada
Chart 46: North American Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 47: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 48: North American SPECT Radioisotopes Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 49: Glance at 2016, 2019 and 2025 North American SPECT Radioisotopes Market Share (%) by Geographic Region – United States and Canada
Chart 50: North American PET Radioisotopes Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 51: Glance at 2016, 2019 and 2025 North American PET Radioisotopes Market Share (%) by Geographic Region – United States and Canada
Chart 52: North American Beta Emitters Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 53: Glance at 2016, 2019 and 2025 North American Beta Emitters Market Share (%) by Geographic Region – United States and Canada
Chart 54: North American Alpha Emitters Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 55: Glance at 2016, 2019 and 2025 North American Alpha Emitters Market Share (%) by Geographic Region – United States and Canada
Chart 56: North American Other Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – United States and Canada in USD Million
Chart 57: Glance at 2016, 2019 and 2025 North American Other Radiopharmaceuticals Market Share (%) by Geographic Region – United States and Canada
Chart 58: North American Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 59: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other
Chart 60: North American Radiopharmaceuticals Market Analysis (2016-2025) in Oncology by Geographic Region – United States and Canada in USD Million
Chart 61: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) in Oncology by Geographic Region – United States and Canada
Chart 62: North American Radiopharmaceuticals Market Analysis (2016-2025) in Cardiology by Geographic Region – United States and Canada in USD Million
Chart 63: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) in Cardiology by Geographic Region – United States and Canada
Chart 64: North American Radiopharmaceuticals Market Analysis (2016-2025) in Neurology by Geographic Region – United States and Canada in USD Million
Chart 65: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) in Neurology by Geographic Region – United States and Canada
Chart 66: North American Radiopharmaceuticals Market Analysis (2016-2025) in Endocrinology by Geographic Region – United States and Canada in USD Million
Chart 67: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) in Endocrinology by Geographic Region – United States and Canada
Chart 68: North American Radiopharmaceuticals Market Analysis (2016-2025) in Other Applications by Geographic Region – United States and Canada in USD Million
Chart 69: Glance at 2016, 2019 and 2025 North American Radiopharmaceuticals Market Share (%) in Other Applications by Geographic Region – United States and Canada

The United States
Chart 70: United States Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 71: United States Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 72: Glance at 2016, 2019 and 2025 United States Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 73: United States Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 74: Glance at 2016, 2019 and 2025 United States Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Canada
Chart 75: Canadian Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 76: Canadian Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 77: Glance at 2016, 2019 and 2025 Canadian Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 78: Canadian Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 79: Glance at 2016, 2019 and 2025 Canadian Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

EUROPE
Chart 80: European Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 81: European Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 82: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 83: European Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 84: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 85: European SPECT Radioisotopes Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 86: Glance at 2016, 2019 and 2025 European SPECT Radioisotopes Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 87: European PET Radioisotopes Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 88: Glance at 2016, 2019 and 2025 European PET Radioisotopes Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 89: European Beta Emitters Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 90: Glance at 2016, 2019 and 2025 European Beta Emitters Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 91: European Alpha Emitters Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 92: Glance at 2016, 2019 and 2025 European Alpha Emitters Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 93: European Other Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 94: Glance at 2016, 2019 and 2025 European Other Radiopharmaceuticals Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 95: European Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 96: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other
Chart 97: European Radiopharmaceuticals Market Analysis (2016-2025) in Oncology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 98: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) in Oncology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 99: European Radiopharmaceuticals Market Analysis (2016-2025) in Cardiology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 100: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) in Cardiology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 101: European Radiopharmaceuticals Market Analysis (2016-2025) in Neurology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 102: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) in Neurology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 103: European Radiopharmaceuticals Market Analysis (2016-2025) in Endocrinology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 104: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) in Endocrinology by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe
Chart 105: European Radiopharmaceuticals Market Analysis (2016-2025) in Other Applications by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe in USD Million
Chart 106: Glance at 2016, 2019 and 2025 European Radiopharmaceuticals Market Share (%) in Other Applications by Geographic Region – Germany, United Kingdom, France, Italy, Sweden and Rest of Europe

Germany
Chart 107: German Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 108: German Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 109: Glance at 2016, 2019 and 2025 German Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 110: German Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 111: Glance at 2016, 2019 and 2025 German Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

The United Kingdom
Chart 112: United Kingdom Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 113: United Kingdom Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 114: Glance at 2016, 2019 and 2025 United Kingdom Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 115: United Kingdom Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 116: Glance at 2016, 2019 and 2025 United Kingdom Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

France
Chart 117: French Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 118: French Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 119: Glance at 2016, 2019 and 2025 French Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 120: French Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 121: Glance at 2016, 2019 and 2025 French Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Italy
Chart 122: Italian Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 123: Italian Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 124: Glance at 2016, 2019 and 2025 Italian Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 125: Italian Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 126: Glance at 2016, 2019 and 2025 Italian Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Sweden
Chart 127: Swedish Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 128: Swedish Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 129: Glance at 2016, 2019 and 2025 Swedish Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 130: Swedish Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 131: Glance at 2016, 2019 and 2025 Swedish Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Rest of Europe
Chart 132: Rest of Europe Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 133: Rest of Europe Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 134: Glance at 2016, 2019 and 2025 Rest of Europe Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 135: Rest of Europe Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 136: Glance at 2016, 2019 and 2025 Rest of Europe Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

ASIA-PACIFIC
Chart 137: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 138: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 139: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 140: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 141: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 142: Asia-Pacific SPECT Radioisotopes Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 143: Glance at 2016, 2019 and 2025 Asia-Pacific SPECT Radioisotopes Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 144: Asia-Pacific PET Radioisotopes Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 145: Glance at 2016, 2019 and 2025 Asia-Pacific PET Radioisotopes Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 146: Asia-Pacific Beta Emitters Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 147: Glance at 2016, 2019 and 2025 Asia-Pacific Beta Emitters Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 148: Asia-Pacific Alpha Emitters Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 149: Glance at 2016, 2019 and 2025 Asia-Pacific Alpha Emitters Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 150: Asia-Pacific Other Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 151: Glance at 2016, 2019 and 2025 Asia-Pacific Other Radiopharmaceuticals Market Share (%) by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 152: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 153: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other
Chart 154: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in Oncology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 155: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) in Oncology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 156: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in Cardiology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 157: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) in Cardiology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 158: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in Neurology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 159: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) in Neurology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 160: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in Endocrinology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 161: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) in Endocrinology by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
Chart 162: Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in Other Applications by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in USD Million
Chart 163: Glance at 2016, 2019 and 2025 Asia-Pacific Radiopharmaceuticals Market Share (%) in Other Applications by Geographic Region – Japan, China, India, Australia, South Korea and Rest of Asia-Pacific

Japan
Chart 164: Japanese Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 165: Japanese Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 166: Glance at 2016, 2019 and 2025 Japanese Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 167: Japanese Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 168: Glance at 2016, 2019 and 2025 Japanese Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

China
Chart 169: Chinese Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 170: Chinese Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 171: Glance at 2016, 2019 and 2025 Chinese Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 172: Chinese Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 173: Glance at 2016, 2019 and 2025 Chinese Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

India
Chart 174: Indian Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 175: Indian Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 176: Glance at 2016, 2019 and 2025 Indian Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 177: Indian Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 178: Glance at 2016, 2019 and 2025 Indian Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Australia
Chart 179: Australian Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 180: Australian Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 181: Glance at 2016, 2019 and 2025 Australian Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 182: Australian Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 183: Glance at 2016, 2019 and 2025 Australian Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

South Korea
Chart 184: South Korean Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 185: South Korean Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 186: Glance at 2016, 2019 and 2025 South Korean Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 187: South Korean Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 188: Glance at 2016, 2019 and 2025 South Korean Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Rest of Asia-Pacific
Chart 189: Rest of Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 190: Rest of Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 191: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 192: Rest of Asia-Pacific Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 193: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

REST OF WORLD
Chart 194: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 195: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 196: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 197: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 198: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 199: Rest of World SPECT Radioisotopes Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 200: Glance at 2016, 2019 and 2025 Rest of World SPECT Radioisotopes Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 201: Rest of World PET Radioisotopes Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 202: Glance at 2016, 2019 and 2025 Rest of World PET Radioisotopes Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 203: Rest of World Beta Emitters Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 204: Glance at 2016, 2019 and 2025 Rest of World Beta Emitters Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 205: Rest of World Alpha Emitters Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 206: Glance at 2016, 2019 and 2025 Rest of World Alpha Emitters Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 207: Rest of World Other Radiopharmaceuticals Market Analysis (2016-2025) by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 208: Glance at 2016, 2019 and 2025 Rest of World Other Radiopharmaceuticals Market Share (%) by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 209: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 210: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other
Chart 211: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in Oncology by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 212: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) in Oncology by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 213: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in Cardiology by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 214: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) in Cardiology by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 215: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in Neurology by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 216: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) in Neurology by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 217: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in Endocrinology by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 218: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) in Endocrinology by Geographic Region – Mexico, Brazil and Other ROW Countries
Chart 219: Rest of World Radiopharmaceuticals Market Analysis (2016-2025) in Other Applications by Geographic Region – Mexico, Brazil and Other ROW Countries in USD Million
Chart 220: Glance at 2016, 2019 and 2025 Rest of World Radiopharmaceuticals Market Share (%) in Other Applications by Geographic Region – Mexico, Brazil and Other ROW Countries

Mexico
Chart 221: Mexican Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 222: Mexican Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 223: Glance at 2016, 2019 and 2025 Mexican Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 224: Mexican Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 225: Glance at 2016, 2019 and 2025 Mexican Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Brazil
Chart 226: Brazilian Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 227: Brazilian Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 228: Glance at 2016, 2019 and 2025 Brazilian Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 229: Brazilian Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 230: Glance at 2016, 2019 and 2025 Brazilian Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Other Rest of World
Chart 231: Other ROW Countries Radiopharmaceuticals Market Analysis (2016-2025) in USD Million
Chart 232: Other ROW Countries Radiopharmaceuticals Market Analysis (2016-2025) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other in USD Million
Chart 233: Glance at 2016, 2019 and 2025 Other ROW Countries Radiopharmaceuticals Market Share (%) by Product Type – SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other
Chart 234: Other ROW Countries Radiopharmaceuticals Market Analysis (2016-2025) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other in USD Million
Chart 235: Glance at 2016, 2019 and 2025 Other ROW Countries Radiopharmaceuticals Market Share (%) by Application – Oncology, Cardiology, Neurology, Endocrinology and Other

Tables:
Table 1: List of Widely Used Radiopharmaceuticals
Table 2: List of Few Cyclotron Produced Radionuclides
Table 3: List of FDA Approved Radiopharmaceuticals

Samples

Companies Mentioned

• Advanced Accelerator Applications SA
• Alpha Tau Medical Ltd.
• Bayer AG
• Blue Earth Diagnostics Limited
• Bracco Diagnostics, Inc.
• Cardinal Health, Inc.
• Clarity Pharmaceuticals
• Curium Pharma
• Eckert & Ziegler Group
• Eczacibasi-Monrol
• GE Healthcare
• Ion Beam Applications SA (IBA)
• Jubilant DraxImage, Inc. dba Jubilant Radiopharma
• Lantheus Medical Imaging, Inc.
• Life Molecular Imaging GmbH
• NTP Radioisotopes SOC Ltd.
• Orano Med
• Siemens Healthineers
• Telix Pharmaceuticals Limited

Methodology